Fetal microchimerisms in the mother: Immunologic implications

Atsushi Tanaka, Keith Lindor, Aftab Ansari, M. Eric Gershwin

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The previously held concept that the fetus is completely separated from the mother, especially by trophoblasts that line the outer layer of the placenta, has recently been questioned. It has recently been shown that fetal cells are detectable not only in the peripheral blood, but also in maternal skin and liver. Although the migration of fetal cells into the maternal circulation has been given a great deal of attention because of its implication in the prenatal diagnosis of genetic diseases, the potential role of such placental transfer of fetal cells in the pathogenesis of autoimmune diseases has only recently been considered. In patients with scleroderma, fetal cell-derived DNA was detected more frequently in the peripheral blood of patients than controls. This finding of a limited number of fetal cells in maternal tissues leading to microchimerism has been proposed to have a role in the induction of scleroderma. Although evidence for microchimerism has also been confirmed in a high frequency of liver tissues from patients with primary biliary cirrhosis (PBC), a similar high frequency was noted in control patients, which suggests that microchimerism by itself is unlikely to fully account for the pathogenesis of PBC. The finding of such a high frequency of fetal microchimerism in the liver suggests that this is a very common event, raising the possibility that the migration of fetal cells may be important in the induction and subsequent maintenance of tolerance against the fetus during pregnancy. In addition, it is clearly possible that such microchimerism could contribute to the pathogenesis of select autoimmune diseases. (C) 2000 by the American Association for the Study of Liver Diseases.

Original languageEnglish (US)
Pages (from-to)138-143
Number of pages6
JournalLiver Transplantation
Volume6
Issue number2
StatePublished - Mar 2000
Externally publishedYes

Fingerprint

Chimerism
Mothers
Biliary Liver Cirrhosis
Autoimmune Diseases
Cell Movement
Liver
Fetus
Inborn Genetic Diseases
Trophoblasts
Prenatal Diagnosis
Placenta
Cell Count
Maintenance
Pregnancy
Skin
DNA

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Tanaka, A., Lindor, K., Ansari, A., & Gershwin, M. E. (2000). Fetal microchimerisms in the mother: Immunologic implications. Liver Transplantation, 6(2), 138-143.

Fetal microchimerisms in the mother : Immunologic implications. / Tanaka, Atsushi; Lindor, Keith; Ansari, Aftab; Gershwin, M. Eric.

In: Liver Transplantation, Vol. 6, No. 2, 03.2000, p. 138-143.

Research output: Contribution to journalArticle

Tanaka, A, Lindor, K, Ansari, A & Gershwin, ME 2000, 'Fetal microchimerisms in the mother: Immunologic implications', Liver Transplantation, vol. 6, no. 2, pp. 138-143.
Tanaka, Atsushi ; Lindor, Keith ; Ansari, Aftab ; Gershwin, M. Eric. / Fetal microchimerisms in the mother : Immunologic implications. In: Liver Transplantation. 2000 ; Vol. 6, No. 2. pp. 138-143.
@article{39a9823182a44a709251669ac50fe2c9,
title = "Fetal microchimerisms in the mother: Immunologic implications",
abstract = "The previously held concept that the fetus is completely separated from the mother, especially by trophoblasts that line the outer layer of the placenta, has recently been questioned. It has recently been shown that fetal cells are detectable not only in the peripheral blood, but also in maternal skin and liver. Although the migration of fetal cells into the maternal circulation has been given a great deal of attention because of its implication in the prenatal diagnosis of genetic diseases, the potential role of such placental transfer of fetal cells in the pathogenesis of autoimmune diseases has only recently been considered. In patients with scleroderma, fetal cell-derived DNA was detected more frequently in the peripheral blood of patients than controls. This finding of a limited number of fetal cells in maternal tissues leading to microchimerism has been proposed to have a role in the induction of scleroderma. Although evidence for microchimerism has also been confirmed in a high frequency of liver tissues from patients with primary biliary cirrhosis (PBC), a similar high frequency was noted in control patients, which suggests that microchimerism by itself is unlikely to fully account for the pathogenesis of PBC. The finding of such a high frequency of fetal microchimerism in the liver suggests that this is a very common event, raising the possibility that the migration of fetal cells may be important in the induction and subsequent maintenance of tolerance against the fetus during pregnancy. In addition, it is clearly possible that such microchimerism could contribute to the pathogenesis of select autoimmune diseases. (C) 2000 by the American Association for the Study of Liver Diseases.",
author = "Atsushi Tanaka and Keith Lindor and Aftab Ansari and Gershwin, {M. Eric}",
year = "2000",
month = "3",
language = "English (US)",
volume = "6",
pages = "138--143",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Fetal microchimerisms in the mother

T2 - Immunologic implications

AU - Tanaka, Atsushi

AU - Lindor, Keith

AU - Ansari, Aftab

AU - Gershwin, M. Eric

PY - 2000/3

Y1 - 2000/3

N2 - The previously held concept that the fetus is completely separated from the mother, especially by trophoblasts that line the outer layer of the placenta, has recently been questioned. It has recently been shown that fetal cells are detectable not only in the peripheral blood, but also in maternal skin and liver. Although the migration of fetal cells into the maternal circulation has been given a great deal of attention because of its implication in the prenatal diagnosis of genetic diseases, the potential role of such placental transfer of fetal cells in the pathogenesis of autoimmune diseases has only recently been considered. In patients with scleroderma, fetal cell-derived DNA was detected more frequently in the peripheral blood of patients than controls. This finding of a limited number of fetal cells in maternal tissues leading to microchimerism has been proposed to have a role in the induction of scleroderma. Although evidence for microchimerism has also been confirmed in a high frequency of liver tissues from patients with primary biliary cirrhosis (PBC), a similar high frequency was noted in control patients, which suggests that microchimerism by itself is unlikely to fully account for the pathogenesis of PBC. The finding of such a high frequency of fetal microchimerism in the liver suggests that this is a very common event, raising the possibility that the migration of fetal cells may be important in the induction and subsequent maintenance of tolerance against the fetus during pregnancy. In addition, it is clearly possible that such microchimerism could contribute to the pathogenesis of select autoimmune diseases. (C) 2000 by the American Association for the Study of Liver Diseases.

AB - The previously held concept that the fetus is completely separated from the mother, especially by trophoblasts that line the outer layer of the placenta, has recently been questioned. It has recently been shown that fetal cells are detectable not only in the peripheral blood, but also in maternal skin and liver. Although the migration of fetal cells into the maternal circulation has been given a great deal of attention because of its implication in the prenatal diagnosis of genetic diseases, the potential role of such placental transfer of fetal cells in the pathogenesis of autoimmune diseases has only recently been considered. In patients with scleroderma, fetal cell-derived DNA was detected more frequently in the peripheral blood of patients than controls. This finding of a limited number of fetal cells in maternal tissues leading to microchimerism has been proposed to have a role in the induction of scleroderma. Although evidence for microchimerism has also been confirmed in a high frequency of liver tissues from patients with primary biliary cirrhosis (PBC), a similar high frequency was noted in control patients, which suggests that microchimerism by itself is unlikely to fully account for the pathogenesis of PBC. The finding of such a high frequency of fetal microchimerism in the liver suggests that this is a very common event, raising the possibility that the migration of fetal cells may be important in the induction and subsequent maintenance of tolerance against the fetus during pregnancy. In addition, it is clearly possible that such microchimerism could contribute to the pathogenesis of select autoimmune diseases. (C) 2000 by the American Association for the Study of Liver Diseases.

UR - http://www.scopus.com/inward/record.url?scp=0034067202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034067202&partnerID=8YFLogxK

M3 - Article

C2 - 10719011

AN - SCOPUS:0034067202

VL - 6

SP - 138

EP - 143

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 2

ER -